Publication
HIV infection and AIDS - Annual Epidemiological Report for 2017
This report is based on HIV surveillance data reported by 30 Member States of the European Union/European Economic Area (EU/EEA) (all except Germany) and AIDS data reported by 28 EU/EEA countries (all except Belgium, Germany and Sweden) for 2017. All countries annually report case-based data to the TESSy HIV/AIDS database in accordance with standard EU case definitions [4]. The database is jointly coordinated by ECDC and the WHO Regional Office for Europe.
Publication
Continuum of HIV care - Monitoring implementation of the Dublin Declaration - 2018 progress report
This report focuses on data findings on the continuum of HIV care submitted by countries in Europe and Central Asia for the 2018 round of reporting on implementation of the Dublin Declaration on Partnership to Fight HIV & AIDS in Europe and Central Asia.
Publication
HIV Estimates Accuracy Tool manual
The HIV Estimates Accuracy Tool is an R-based application that uses statistical methods to allow for adjusted estimates from HIV surveillance data taking into account the issues of missing data and reporting delay. While it does not replace the knowledge of data analysis with adjustments, it is intended for routine application in surveillance as no complex programming skills are needed.
Peer-Reviewed Publication
Are European HIV cohort data within EuroCoord representative of the diagnosed HIV population?
Vourli, G., Pharris, A., Cazein, F., Costagliola, D., Dabis, F., Del Amo, J., Delpech, V., Diaz, E., Girardi, A., Gourlay, A., Gunsenheimer-Bartmeyer, B., Hernando, V., Nikolopoulos, G., Porter, K., Rosinska, M., Sabin, C., Suligoi, B. Supervie, V., Wit, F., Touloumi, G.
Data
Surveillance systems overview for 2017
This spreadsheet contains all surveillance system overview tables from ECDC's annual epidemiological report for 2017.
- anthrax
- botulism
- campylobacteriosis
- chikungunya
- Chlamydia infection
- cholera
- Crimean-Congo haemorrhagic fever
- cryptosporidiosis
- dengue
- diphtheria
- Ebola haemorrhagic fever
- echinococcosis
- EU/EEA
- giardiasis
- hantavirus infection
- healthcare-associated infections
- hepatitis A
- hepatitis B
- hepatitis C
- HIV infection
- influenza
- invasive Haemophilus influenzae disease
- Lassa fever
- leptospirosis
- listeriosis
- malaria
- Marburg haemorrhagic fever
- meningococcal disease
- mumps
- pertussis
- plague
- pneumococcal disease
- poliomyelitis
- Q fever
- rabies
- Rift Valley fever
- salmonellosis
- severe acute respiratory syndrome
- shigellosis
- smallpox
- surgical site infections
- surveillance
- tuberculosis
- verotoxigenic Escherichia coli infection
- West Nile fever
- yellow fever
Peer-Reviewed Publication
Quantifying unmet prevention needs among msm in europe through a multi-site bio-behavioural survey
Mirandola, M., Gios, L., Sherriff, N., Marcus, U., Toskin, I., Rosinska, M., Schink, S., Kühlmann-Berenzon, S., Suligoi, B., Folch, C., Nöstlinger, C., Dias, S., Stanekova, D., Klavs, I., Caplinskas, S., Rafila, A., Marin, C., Alexiev, I., Zohrabyan, L., Noori, T., Menel-Lemos, C.
Publication
Public health guidance in brief on HIV, hepatitis B and C testing in the EU/EEA
The ECDC guidance on integrated testing of hepatitis B (HBV), hepatitis C (HCV) and HIV supports countries in the global effort to combat viral hepatitis and eliminate HIV as public health threats by 2030. At present, reaching and testing those at risk of infection with HIV, HBV or HCV is still a public health challenge across Europe. This Guidance in brief is based on the comprehensive guidance document which provides the evidence base for this guidance
Peer-Reviewed Publication
Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016
Day, M.J., Spiteri, G., Jacobsson, S., Woodford, N., Amato-Gauci, A.J., Cole, M.J., Unemo, M., Indra, A., Huhlescu, S., Vanden Berghe, W., Crucitti, T., Hunjak, B., Nemeth Blažić, T., Kubele, J., Zákoucká, H., Žemličková, H., Berthelsen, L., Cowan, S., Hoffmann, S., Epstein, J., Viktorova, J., Ndeikoundam, N., Goubard, A., Bercot, B., Kohl, P., Buder, S., Bremer, V., Jansen, K., Tzelepi, E., Konte, V., Balla, E., Dudás, M., Sigmundsdóttir, G., Hauksdóttir, G.S., Igoe, D., Crowley, B., Suligoi, B., Stefanelli, P., Pakarna, G., Mavcutko, V., Reichert, P., Hoffmann, P., Barbara, C., Vella, F., Melillo, J.M., Van Dam, A., Van Benthem, B., Linde, I., Kløvstad, H., Steinbakk, M., Majewski, S., Młynarczyk-Bonikowska, B., Azevedo, J., Borrego, M.-J., Pavlik, P., Truska, P., Klavs, I., Jeverica, S., Vazquez, J., Diaz, A., Abad, R., Velicko, I., Hughes, G., Templeton, K., Irvine, N.
Data
Infographic: HIV and AIDS in Europe 2017
Europe experiences a persistent HIV epidemic, with only little changes in notifications during the last decade in the EU/EEA. One reason for this: an estimated 120 000 Europeans are living with undiagnosed HIV in the EU/EEA, which means that about 1 in 5 (15 %) of those living with HIV are not aware of their status. And it takes around three years from HIV infection to diagnosis.
Data
Infographic: HIV late Diagnosis - 2017 data
In the EU/EEA, almost every second HIV diagnosis happened at a late stage in 2017. This means diagnosis several years after infection.
In 2007, 49 % of those with a CD4 cell count reported at HIV diagnosis were diagnosed late (several years after infection).